• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

司他夫定(D4T)及其5'-单磷酸前药的合成与抗HIV活性评价

Synthesis and anti-HIV evaluation of D4T and D4T 5'-monophosphate prodrugs.

作者信息

Sergheraert C, Pierlot C, Tartar A, Henin Y, Lemaitre M

机构信息

Faculté de Pharmacie, Institut Pasteur de Lille, URA CNRS 1309, Lille, France.

出版信息

J Med Chem. 1993 Apr 2;36(7):826-30. doi: 10.1021/jm00059a006.

DOI:10.1021/jm00059a006
PMID:8385224
Abstract

Several 5-monophosphate D4T derivatives and their analogues were synthesized as potential lipophilic prodrugs of D4T. Cholesteryl D4T phosphate diester and bis-5'-D4T phosphate inhibited HIV replication in CEM-Cl13 cells more efficiently than D4T itself as measured by the inhibition of cytopathic effect based on MTT assay or reverse transcriptase activity. The two compounds were devoid of toxicity on CEM-Cl13 cells at doses equal to 50 and 100 microM, respectively, which brought the selectivity index into the same range as AZT.

摘要

合成了几种5-单磷酸双脱氧胸苷(D4T)衍生物及其类似物,作为D4T潜在的亲脂性前药。通过基于MTT法的细胞病变效应抑制或逆转录酶活性测定,胆固醇基D4T磷酸二酯和双-5'-D4T磷酸酯在CEM-Cl13细胞中抑制HIV复制的效率比D4T本身更高。这两种化合物在分别等于50和100微摩尔的剂量下对CEM-Cl13细胞无毒性,这使得选择性指数与齐多夫定(AZT)处于相同范围。

相似文献

1
Synthesis and anti-HIV evaluation of D4T and D4T 5'-monophosphate prodrugs.司他夫定(D4T)及其5'-单磷酸前药的合成与抗HIV活性评价
J Med Chem. 1993 Apr 2;36(7):826-30. doi: 10.1021/jm00059a006.
2
Marked inhibitory activity of masked aryloxy aminoacyl phosphoramidate derivatives of dideoxynucleoside analogues against visna virus infection.双脱氧核苷类似物的掩蔽芳氧基氨基酰基磷酰胺酯衍生物对维斯纳病毒感染具有显著的抑制活性。
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):296-302. doi: 10.1097/00042560-199804010-00002.
3
1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent.1-(2,3-二脱氧-β-D-甘油-戊-2-烯呋喃糖基)胸腺嘧啶。一种高效且选择性的抗HIV药物。
J Med Chem. 1989 Feb;32(2):461-6. doi: 10.1021/jm00122a029.
4
Bis-cycloSal-d4T-monophosphates: drugs that deliver two molecules of bioactive nucleotides.双环水杨酸-d4T-单磷酸酯:可递送两分子生物活性核苷酸的药物。
J Med Chem. 2007 Mar 22;50(6):1335-46. doi: 10.1021/jm0611713. Epub 2007 Mar 1.
5
Diastereoselective synthesis of aryloxy phosphoramidate prodrugs of 3'-deoxy-2',3'-didehydrothymidine monophosphate.手性选择性合成 3'-脱氧-2',3'-二去氢胸苷单磷酸芳氧基磷酰胺酯前药。
J Med Chem. 2010 Nov 11;53(21):7675-81. doi: 10.1021/jm100817f.
6
Glycosyl-oxycarbonylaminosulfonyl-2',3'-dideoxynucleoside derivatives as lipophilic nucleotide mimics. Synthesis and anti-HIV activity.
Bioorg Med Chem. 1993 Oct;1(4):279-84. doi: 10.1016/s0968-0896(00)82133-1.
7
Synthesis and antiviral (HIV-1, HBV) activities of 5-halo-6-methoxy(or azido)-5,6-dihydro-3'-fluoro-3'-deoxythymidine diastereomers. Potential prodrugs to 3'-fluoro-3'-deoxythymidine.5-卤代-6-甲氧基(或叠氮基)-5,6-二氢-3'-氟-3'-脱氧胸苷非对映异构体的合成及其抗病毒(HIV-1、HBV)活性。3'-氟-3'-脱氧胸苷的潜在前体药物。
J Med Chem. 1994 Oct 14;37(21):3554-60. doi: 10.1021/jm00047a013.
8
Nucleoside mono- and diphosphate prodrugs of 2',3'-dideoxyuridine and 2',3'-dideoxy-2',3'-didehydrouridine.2',3'-二脱氧尿苷和2',3'-二脱氧-2',3'-二氢尿苷的核苷单磷酸和二磷酸前药。
ChemMedChem. 2015 Jan;10(1):94-106. doi: 10.1002/cmdc.201402295. Epub 2014 Sep 10.
9
Anti-human immunodeficiency virus type 1 activities of dideoxynucleoside phosphotriester derivatives in primary monocytes/macrophages.双脱氧核苷磷酸三酯衍生物在原代单核细胞/巨噬细胞中的抗人免疫缺陷病毒1型活性
Res Virol. 1996 Mar-Jun;147(2-3):155-63. doi: 10.1016/0923-2516(96)80230-5.
10
Design and synthesis of lipophilic phosphoramidate d4T-MP prodrugs expressing high potency against HIV in cell culture: structural determinants for in vitro activity and QSAR.亲脂性磷酸酰胺酯d4T-MP前药的设计与合成:在细胞培养中对HIV具有高效力,体外活性的结构决定因素和定量构效关系
J Med Chem. 1999 Oct 7;42(20):4122-8. doi: 10.1021/jm9807104.

引用本文的文献

1
Stavudine: a review of its pharmacodynamic and pharmacokinetic properties and clinical potential in HIV infection.
Drugs. 1996 May;51(5):846-64. doi: 10.2165/00003495-199651050-00009.